佩奥尼弗洛林通过调节微质M1极化和纠正 kynurenine 途径失调来减轻神经病变与疼痛相关的抑郁症
Jianjun Cheng1, Yang Gao1, Pei Liu1
1Hebei Key Laboratory of Research and Development for Chinese Medicine, Chengde Medical University, Hebei, Chengde 067000, China.
International immunopharmacology
|August 13, 2025
概括
佩奥尼佛洛林 (PF) 通过向微质M1极化和金氨酸通路 (KP) 来缓解神经病痛相关的抑郁症. 这项研究揭示了PF PF.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
背景情况:
- 神经病痛 (NP) 是一种慢性压力因素,通过神经免疫失调与抑郁症有关.
- 在NP相关抑郁症中,微质偏极化与 kynurenine 途径 (KP) 代谢之间的相互作用尚未完全理解.
研究的目的:
- 为了研究帕伊尼弗洛林 (PF) 在缓解NP相关抑郁症方面的治疗潜力.
- 探索PF的作用机制,重点关注微质M1极化和金氨酸3-单氧酶 (KMO) 途径.
主要方法:
- 使用慢性收缩损伤 (CCI) 鼠标神经病痛模型.
- 施用了氨酸 (PF) 并评估了微质极化,KMO活性,氨酸 (QUIN) 水平和神经元亡.
- 使用药理抑制剂 (米诺环素,Ro 61-8048) 和体外BV-2细胞实验.
主要成果:
- CCI诱导了持续的海马微质M1极化和高的KMO,导致QUIN介导的神经毒性和类似抑郁症的行为.
- PF治疗降低了M1极化,KMO活性和QUIN水平,减轻了神经元损伤和抑郁症状.
- 药理上抑制M1极化或KMO模仿了PF的抗抑郁作用.
结论:
- PF作为神经性疼痛相关抑郁症的多目标治疗剂.
- PF破坏了STAT1-M1-KMO通路,为治疗NP相关抑郁症提供了一种新方法.
- 调节神经免疫代谢交叉是NP并发症的一个有希望的策略.
相关概念视频
Analgesia and Pain Management
791
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
791
Antidepressant Drugs: MAOIs and Other Agents
349
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
349
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K


